Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD
Medical cannabis provider aims to accelerate research efforts throughout North AmericaTORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Canada’s leading provider...
Medical cannabis provider aims to accelerate research efforts throughout North AmericaTORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Canada’s leading provider...
Program advances research in diversity, equity and inclusion in healthcareCARY, N.C., March 16, 2021 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee),...
Continued enrollment in expanded ADXS-503 HOT program in NSCLC to explore potential to enhance and/or restore sensitivity to checkpoint inhibitors...
New subsidiary will further the Company’s research into treating COVID-related heart muscle injury. A patent has been filed for a...
TORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
DENVER, CO, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”)...
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology,...
The two neurology device companies will join forces in a clinical trial seeking to reduce the symptoms of autism in...
BrightInsight Accelerates Time to Market for the AstraZeneca AMAZE Disease Management Platform Within a Regulatory-Compliant Environment BrightInsight and AstraZeneca Collaborate...
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice” or the “Company”), an animal...
San Diego, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical...
Phase 2 AFFINITY Trial of Atrasentan for Patients with Glomerular Diseases Also on Track to Begin Enrollment in the First...
VANCOUVER, B.C. / BOSTON, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)...
SAFEbody technology enables precision masking of antibodies for enhanced safetySAN FRANCISCO and SUZHOU, China, March 16, 2021 (GLOBE NEWSWIRE) --...
Reported top-line results from Phase 2 SIGNAL study that indicates potential cognitive benefit of pepinemab in neurodegenerative disease. New Alzheimer’s...
AUSTIN, Texas, March 16, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr....
The Leader in Telehealth Broadens Oral Care Retail Presence with Walmart Partnership SmileDirectClub Electric Toothbrush SmileDirectClub's innovative oral care products...
Effectiveness and Utility of SRT-100™ Demonstrated in the Companion-Animal Market Best-in-class localization features of SRT-100 enable new radiation therapy options...
New Phase IIb trial called TACTI-003, to evaluate eftilagimod alpha in combination with MSD’s KEYTRUDA® (pembrolizumab) in 1st line head...
Accelerating Scale by Expanding Geographical Operating Footprint with New Location in Florida and New HampshireCINCINNATI, March 16, 2021 (GLOBE NEWSWIRE)...